The use of asthma controller medications during pregnancy and the risk of gestational diabetes - 18/04/17
This work was supported by a grant from the Canadian Institutes of Health Research (grant no. 126153). |
|
Disclosure of potential conflict of interest: M.-F. Beauschesne has received grants and personal fees from Novartis and AstraZeneca. L. Blais has received grants from the Canadian Institutes for Health Research, AstraZeneca, and GlaxoSmithKline and has received personal fees from AstraZeneca and GlaxoSmithKline. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 138 - N° 6
P. 1732 - décembre 2016 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?